Ronan McMullan

1.9k total citations
54 papers, 1.0k citations indexed

About

Ronan McMullan is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Ronan McMullan has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 23 papers in Epidemiology and 18 papers in Clinical Biochemistry. Recurrent topics in Ronan McMullan's work include Antifungal resistance and susceptibility (18 papers), Bacterial Identification and Susceptibility Testing (18 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Ronan McMullan is often cited by papers focused on Antifungal resistance and susceptibility (18 papers), Bacterial Identification and Susceptibility Testing (18 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Ronan McMullan collaborates with scholars based in United Kingdom, Ireland and Netherlands. Ronan McMullan's co-authors include Daniel F. McAuley, S. Hedderwick, Paul Dark, Gavin D. Perkins, Bronagh Blackwood, C.H. Webb, R. J. Hay, Peter Coyle, Lobna Metwally and Fionnuala T. Lundy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ronan McMullan

52 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronan McMullan United Kingdom 18 478 451 240 142 128 54 1.0k
Elizabeth Palavecino United States 22 472 1.0× 529 1.2× 312 1.3× 210 1.5× 169 1.3× 89 1.4k
Christian Chuard Switzerland 17 486 1.0× 415 0.9× 271 1.1× 211 1.5× 154 1.2× 49 1.1k
L. Bode Netherlands 15 298 0.6× 724 1.6× 221 0.9× 257 1.8× 165 1.3× 32 1.4k
Kirsi Skogberg Finland 12 304 0.6× 211 0.5× 185 0.8× 224 1.6× 159 1.2× 29 881
E.G. Smyth Ireland 19 373 0.8× 459 1.0× 294 1.2× 114 0.8× 175 1.4× 62 991
Ólafur Guðlaugsson Iceland 11 673 1.4× 997 2.2× 165 0.7× 128 0.9× 80 0.6× 19 1.2k
Frank Kipp Germany 17 264 0.6× 482 1.1× 311 1.3× 334 2.4× 96 0.8× 50 1.1k
G. Młynarczyk Poland 21 469 1.0× 502 1.1× 251 1.0× 290 2.0× 144 1.1× 176 1.4k
B. Pilmis France 20 498 1.0× 339 0.8× 160 0.7× 117 0.8× 95 0.7× 85 1.1k
Aaron E. Glatt United States 17 549 1.1× 679 1.5× 142 0.6× 115 0.8× 113 0.9× 46 1.2k

Countries citing papers authored by Ronan McMullan

Since Specialization
Citations

This map shows the geographic impact of Ronan McMullan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronan McMullan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronan McMullan more than expected).

Fields of papers citing papers by Ronan McMullan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronan McMullan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronan McMullan. The network helps show where Ronan McMullan may publish in the future.

Co-authorship network of co-authors of Ronan McMullan

This figure shows the co-authorship network connecting the top 25 collaborators of Ronan McMullan. A scholar is included among the top collaborators of Ronan McMullan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronan McMullan. Ronan McMullan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coyle, Vicky M., Richard Adams, Ashley Agus, et al.. (2024). Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health Technology Assessment. 28(14). 1–101. 1 indexed citations
2.
Simpson, A. John, Michelle Chatwin, Victoria Ewan, et al.. (2023). BTS clinical statement on aspiration pneumonia. Thorax. 78(Suppl 1). s3–s21. 29 indexed citations
3.
Coyle, Vicky M., Daniel F. McAuley, Richard H. Wilson, et al.. (2023). Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial. Clinical Microbiology and Infection. 30(1). 92–99. 2 indexed citations
4.
Loughlin, Laura, Thomas P Hellyer, P. Lewis White, et al.. (2020). Pulmonary Aspergillosis in Patients with Suspected Ventilator-Associated Pneumonia in UK ICUs. American Journal of Respiratory and Critical Care Medicine. 202(8). 1125–1132. 30 indexed citations
5.
Hellyer, Thomas P, et al.. (2020). How to optimise duration of antibiotic treatment in patients with sepsis?. BMJ. 371. m4357–m4357. 3 indexed citations
6.
7.
Fairley, Derek, Thamarai Schneiders, Robert L. Hill, et al.. (2018). The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism. European Journal of Clinical Microbiology & Infectious Diseases. 37(5). 959–967. 4 indexed citations
8.
White, P. Lewis, et al.. (2017). Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation. Journal of Clinical Pathology. 71(5). 420–424. 15 indexed citations
9.
Nolan, Thomas J., Naomi J. Gadsby, Thomas P Hellyer, et al.. (2016). Low-pathogenicityMycoplasmaspp. alter human monocyte and macrophage function and are highly prevalent among patients with ventilator-acquired pneumonia. Thorax. 71(7). 594–600. 13 indexed citations
10.
Dark, Paul, Claire Wilson, Bronagh Blackwood, et al.. (2012). Accuracy of LightCycler® Septi Fast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol. BMJ Open. 2(1). e000392–e000392. 28 indexed citations
11.
McAuley, Daniel F., et al.. (2010). Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults. Journal of Infection. 61(5). 403–409. 8 indexed citations
12.
Donaldson, Hugo, David M. Livermore, Paul J. Rooney, et al.. (2008). Evaluation of the VITEK(R)2 AST N-054 test card for the detection of extended-spectrum  -lactamase production in Escherichia coli with CTX-M phenotypes. Journal of Antimicrobial Chemotherapy. 62(5). 1015–1017. 7 indexed citations
13.
14.
Williams, Michael, Ronan McMullan, S. Hedderwick, D A Mulholland, & R Best. (2006). Diagnosis and Treatment of Endogenous Fungal Endophthalmitis. Ophthalmologica. 220(2). 134–136. 11 indexed citations
15.
16.
McMullan, Ronan, et al.. (2004). Corticosteroids and peritonsillar abscess formation in infectious mononucleosis. The Journal of Laryngology & Otology. 118(6). 459–461. 9 indexed citations
17.
Moore, John E. & Ronan McMullan. (2003). Comparison of media for optimal recovery ofCandida albicans andCandida glabrata from blood culture. Irish Journal of Medical Science (1971 -). 172(2). 60–62. 4 indexed citations
18.
Millar, B. Cherie, et al.. (2003). Isolation of Alternaria Alternata from an Emollient Cream: Implications for Public Health. Mycopathologia. 156(4). 273–277. 5 indexed citations
19.
McMullan, Ronan, Jianguo Xu, Martin Kelly, et al.. (2002). Mycobacterium triplex Pulmonary Infection in an Immunocompetent Patient. Journal of Infection. 44(4). 263–264. 8 indexed citations
20.
McMullan, Ronan, Jianguo Xu, John E. Moore, et al.. (2002). Candida dubliniensis Bloodstream Infection in Patients with Gynaecological Malignancy. European Journal of Clinical Microbiology & Infectious Diseases. 21(8). 635–636. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Palavecino Breakdown of academic impact, for papers by Christian Chuard Breakdown of academic impact, for papers by L. Bode Breakdown of academic impact, for papers by Kirsi Skogberg Breakdown of academic impact, for papers by E.G. Smyth Breakdown of academic impact, for papers by Ólafur Guðlaugsson Breakdown of academic impact, for papers by Frank Kipp Breakdown of academic impact, for papers by G. Młynarczyk Breakdown of academic impact, for papers by B. Pilmis Breakdown of academic impact, for papers by Aaron E. Glatt
Rankless by CCL
2026